- New Formulation of Rebif(R) Designed to Improve Injection Tolerability Merck Serono, a division of Merck KGaA, announced today that the European Commission has ...
Rebif (interferon beta-1a) is a prescription drug used to treat some types of multiple sclerosis (MS). Rebif may be safe to use while pregnant or breastfeeding. Keep ...
Rebif is used to treat multiple sclerosis and clinically isolated syndrome. It can interact with certain monoclonal antibodies like alemtuzumab and ozanimod, increasing the risk of infection. Drinking ...
DARMSTADT, Germany, May 25, 2016/PRNewswire/. Merck, a leading science and technology company, today announced that clinical data on Rebif(R) (interferon beta-1a ...
The US Food and Drug Administration has approved a single-use autoinjector (Rebidose, EMD Serono Inc./Pfizer Inc) for self-injection of interferon beta-1a (Rebif) in the treatment of relapsing forms ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results